Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US medicare population

Journal of Mental Health Policy and Economics

Volumn 15, Issue 4, 2012, Pages

  Kaplan, Cameron ^a   Zhang, Yuting ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; SERTRALINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; COMPARATIVE STUDY; DEPRESSION; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HOSPITAL; HUMAN; MEDICARE; PATIENT COMPLIANCE; PATIENT REFERRAL; PHARMACY; PRESCRIPTION; SCORING SYSTEM; UNITED STATES; AGE; AGED; COMPARATIVE EFFECTIVENESS; ECONOMICS; INSURANCE; MEDICATION COMPLIANCE; RACE; SEX DIFFERENCE; STATISTICS;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; COMPARATIVE EFFECTIVENESS RESEARCH; CONTINENTAL POPULATION GROUPS; DEPRESSION; HEALTH EXPENDITURES; HUMANS; INSURANCE CLAIM REVIEW; MEDICARE; MEDICATION ADHERENCE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEX FACTORS; UNITED STATES;

MLCS; MLOWN;

EID: 84879813065     PISSN: 10914358     EISSN: 1099176X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Greenberg P, Kessler R, Birnbaum H, Leong SA, Lowe SW, Berglund PA, et al. The economic burden of depression in the US: how did it change between 1990 and 2000? J Clin Psychiatry 2003; 64 (12): 1465-1473.
2. Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States' Medicare population. Health Qual Life Outcomes 2009; 7 (1): 1-11.
3. Geriatric Mental Health Foundation. Late Life Depression - A fact sheet. American Association for Geriatric Psychiatry: 2011. Retrieved November 15, 2011, from http://gmhfonline.org/gmhf/consumer/ factsheets/depression-factsheet. html.
4. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003; 42 (10): 1811-1817.
5. Jiang W, Hasselblad V, Krishnan RR, O'Connor CM. Patients with CHF and depression have greater risk of mortality and morbidity than patients without depression. J Am Coll Cardiol 2002; 39 (5): 919-921.
6. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161 (15): 1849-1856.
7. Carels RA. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res 2004; 13 (1): 63-72.
8. Reynolds CF 3rd, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ. Maintenance Treatment of Major Depression in Old Age. N Engl J Med 2006; 354 (11): 1130-1138.
9. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet 2009; 373 (9665): 746-758.
10. Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol 2005; 45 (10): 1106-1122.
11. Centers for Medicare & Medicaid Services. Centers for Medicare & Medicaid Services Prescription Drug Hierarchical Condition Category (RxHCC) Model Software. 2010. Retrieved February 3, 2010, from http://www.cms.hhs.gov/ MedicareAdvtgSpecRateStats/06-Risk- adjustment.asp.
12. Centers for Medicare & Medicaid Services. Centers for Medicare & Medicaid Services Hierarchical Condition Category (CMS-HCC) Model Software. Baltimore, MD, USA, 2010.
13. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation?: Comparing methods of modeling Medicare expenditures. J Health Econ 2004; 23 (3): 525-542.
14. Becker SO, Ichino A. Estimation of average treatment effects based on propensity scores. The Stata Journal 2002; 2 (4): 358-377.
15. Zhang Y, Baicker K, Newhouse JP. Geographic variation in Medicare drug spending. N Engl J Med 2010; 363(5): 405-409.
16. The Dartmouth Atlas Project. The Dartmouth Atlas of Health Care Quality/Effective Care. Lebanon, NH, 2010.
17. Terza JV, Basu A, Rathouz PJ. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ 2008; 27 (3): 531-543.
18. Angrist J, Krueger AB. Instrumental variables and the search for identification: From supply and demand to natural experiments. National Bureau of Economic Research Cambridge, Mass., USA, 2001.
19. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care 2010; 48 (5): 409-417.
20. Fang G, Brooks JM, Chrischilles EA. A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness research. Med Care 2010; 48 (8): 710-717.
21. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994; 272 (11): 859-866.
22. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297 (3): 278-285.